ecrin-mdr-crcClinical2000Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2004909United States6Recurrent rectal cancerRecurrent colon cancerStage IV rectal cancerTipifarnibStage IV colon cancerAdenocarcinoma of the colonAdenocarcinoma of the rectumECRIN MDRCompletedfalseS9923 R115777 in Treating Patients With Advanced Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of R115777 in treating patients who have recurrent or advanced colorectal cancer.2000-06-152004909NCT00005833